Cargando…

Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinoma

Smoking has been linked to urothelial carcinoma (UC), but the implications on genomic profile and therapeutic response are poorly understood. To determine how smoking history impacts genomic profile and chemotherapy response, clinicopathologic data was collected for patients with metastatic UC (mUC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Monika, Vasekar, Monali, Grivas, Petros, Emamekhoo, Hamid, Hsu, JoAnn, Miller, Vincent A., Stephens, Philip J., Ali, Siraj M., Ross, Jeffrey S., Zhu, Junjia, Warrick, Joshua, Drabick, Joseph J., Holder, Sheldon L., Kaag, Matthew, Li, Min, Pal, Sumanta Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239565/ https://www.ncbi.nlm.nih.gov/pubmed/27213592 http://dx.doi.org/10.18632/oncotarget.9449

Ejemplares similares

ATM/RB1 mutations predict shorter overall survival in urothelial cancer
por: Yin, Ming, et al.
Publicado: (2018)

Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023
por: Joshi, Monika, et al.
Publicado: (2023)

Alterations of DNA damage response genes correlate with response and overall survival in anti‐PD‐1/PD‐L1‐treated advanced urothelial cancer
por: Joshi, Monika, et al.
Publicado: (2020)

Therapeutic approach guided by genetic alteration: Use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression
por: Lipkin, Jacob S, et al.
Publicado: (2015)

Improving Outcomes for Patients With Advanced Urothelial Carcinoma
por: Grivas, Petros, et al.
Publicado: (2020)

Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
por: Andreatos, Nikolaos, et al.
Publicado: (2020)

The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape
por: Koshkin, Vadim S., et al.
Publicado: (2019)

Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
por: Kaag, Matthew G.
Publicado: (2020)

Treatment options for advanced urothelial cancer after progression on chemotherapy and immune checkpoint inhibitors: a literature review
por: Koshkin, Vadim S., et al.
Publicado: (2021)

Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes
por: Li, Huili, et al.
Publicado: (2020)

Compare Breast Cancer Screening, Diagnosis, and Treatment Between Medicare Patients With and Without ADRD
por: Weng, Xingran, et al.
Publicado: (2020)

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2018)

Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature Review
por: Polimera, Hyma, et al.
Publicado: (2020)

Dexamethasone may be the most efficacious corticosteroid for use as monotherapy in castration-resistant prostate cancer
por: Holder, S L, et al.
Publicado: (2015)

Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma
por: Lyou, Yung, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
por: Zhu, Alec, et al.
Publicado: (2023)

Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2021)

Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
por: Grivas, Petros, et al.
Publicado: (2018)

Conditional Survival in de novo Metastatic Urothelial Carcinoma
por: Pal, Sumanta Kumar, et al.
Publicado: (2015)

Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry
por: Peak, Taylor, et al.
Publicado: (2023)

The addition of abemaciclib to sunitinib induces regression of renal cell carcinoma xenograft tumors
por: Small, Jeffrey, et al.
Publicado: (2017)

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)
por: Rosenberg, Jonathan E., et al.
Publicado: (2018)

Spontaneous Hip Dislocation Complicating the Management of Malignant Peripheral Nerve Sheath Tumor Arising Within a Plexiform Neurofibroma
por: Mrowczynski, Oliver D, et al.
Publicado: (2021)

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
por: Ghali, Fady, et al.
Publicado: (2022)

Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma
por: Hoffman-Censits, Jean, et al.
Publicado: (2020)

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
por: Koshkin, Vadim S., et al.
Publicado: (2018)

Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond
por: Zhu, Jason, et al.
Publicado: (2018)

Effect of smoking on urothelial cancer risk in individuals with Lynch syndrome
por: Kohlmann, Wendy, et al.
Publicado: (2010)

Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma
por: Petros, Firas G.
Publicado: (2020)

Renal Cell Carcinoma With Urinary Bladder Metastasis: A Case Report With Metachronous Genomic Analyses
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2021)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
por: Galsky, Matthew D, et al.
Publicado: (2021)

Discovering smoking-related pathway alterations in urothelial cell carcinoma pathogenesis
por: Martignoni, Guido
Publicado: (2013)

Perioperative chemotherapy for muscle-invasive bladder cancer: the importance of multidisciplinary management for evidence-based practice and transformative research
por: Koshkin, Vadim S., et al.
Publicado: (2018)

Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice
por: Tang, Moon-shong, et al.
Publicado: (2019)

Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer
por: Pal, Sumanta K, et al.
Publicado: (2012)

Addressing metastatic individuals everyday: Rationale and design of the nurse AMIE for Amazon Echo Show trial among metastatic breast cancer patients
por: Gordon, Brett R., et al.
Publicado: (2023)

Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer
por: Damrauer, Jeffrey S., et al.
Publicado: (2022)

Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS
por: Yee, Christopher H., et al.
Publicado: (2019)

Cigarette smoke‐induced urothelial cell damage: potential role of platelet‐activating factor
por: Kispert, Shannon E., et al.
Publicado: (2017)

Best Practices for the Formal Software Testing Process: A Menu of Testing Tasks
por: Drabick, Rodger
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hoooodnq6h6f4a1lshrq1nk826